Intra-amniotic ER004 as a prenatal treatment of X-linked hypohidrotic ectodermal dysplasia (XLHED)

Forschungsstelle

INNOSUISSE

Projektnummer

53573.1 IP-LS

Projekttitel

Intra-amniotic ER004 as a prenatal treatment of X-linked hypohidrotic ectodermal dysplasia (XLHED)

Projekttitel Englisch

Intra-amniotic ER004 as a prenatal treatment of X-linked hypohidrotic ectodermal dysplasia (XLHED)

Texte zu diesem Projekt

	Deutsch	Französisch	Italienisch	Englisch
Kurzbeschreibung		-	-
Abstract		-	-	-

Kategorie	Text
Kurzbeschreibung (Deutsch)	Intra-amniotic ER004 as a prenatal treatment of X-linked hypohidrotic ectodermal dysplasia (XLHED)
Kurzbeschreibung (Englisch)	Intra-amniotic ER004 as a prenatal treatment of X-linked hypohidrotic ectodermal dysplasia (XLHED)
Abstract (Deutsch)	ER004 is the first therapy specifically addressing X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED), a rare genetic disorder caused by the lack of a functional ectodysplasin A1 (EDA1) protein. Intra-amniotic treatment with ER004 has the potential to switch off symptoms throughout patients# lives.